Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,724 $ 14,042
Accounts receivable 102 59
Inventory, current 407 488
Prepaid expenses and other current assets 509 781
Total current assets 6,742 15,370
Fixed assets, net 1,101 1,325
Inventory, non-current 374 511
Right-of-use assets 261 428
Other non-current assets 13 13
Total assets 8,491 17,647
Current liabilities:    
Accounts payable and accrued expenses 1,466 1,969
Operating lease liabilities - current 220 245
Other current liabilities 62 53
Current portion of long-term debt, net of unamortized debt discount of $132 and $182, respectively 2,781 2,532
Total current liabilities 4,529 4,799
Contingent royalty obligation 1,212
Operating lease liabilities - non-current 34 178
Convertible note, net of unamortized debt discount of $64 and $108, respectively 3,936 3,892
Long-term debt, net of unamortized debt discount of $44 and $135, respectively 2,470 4,589
Total liabilities 10,969 14,670
Commitments and contingent liabilities (Note 9)
Shareholders’ (deficiency) equity    
Common stock $0.0001 par value; 115,000,000 shares authorized; 530,449 and 310,494 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
Additional paid-in capital 148,935 144,328
Accumulated deficit (151,413) (141,351)
Total shareholders’ (deficiency) equity (2,478) 2,977
Total liabilities and shareholders’ (deficiency) equity $ 8,491 $ 17,647